Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
MRMerck & Co., Inc. logo

Merck & Co., Inc. (MRK)

New York Stock Exchange · Currency in USD
$145.27 ▼ -1.97 (-1.34%)
At close: Oct 23, 4:01 PM ET. Market closed.
$145.32 ▲ +0.05 (+0.03%)
After hours: Oct 23, 7:54 PM ET

Summary

Previous Close
$147.24
Open
$145.02
Day's Range
$143.42 – $145.40
52 Week Range
$82.01 – $156.92
Volume
8,378,881
Avg. Volume
10,282,821
Market Cap
$358.41B
Beta (5Y Monthly)
0.22
PE Ratio (TTM)
115.29
EPS (TTM)
$1.28
Earnings Date
Oct 29, 2026
Forward Dividend & Yield
$3.40 (2.34%)
Ex-Dividend Date
Sep 15, 2026
1y Target Est
$157.94

Profile: Merck & Co., Inc.

Sector
Healthcare
Industry
Drug Manufacturers - General
Full-time employees
74,000
CEO
Robert Davis
Website
merck.com

Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes.

Earnings

Next report: Thu, Oct 29, 2026
EPS estimate $2.09 · Revenue est. $17.31B
DateEst.Actual
Aug 4, 2026-$0.27-$0.13Beat
Apr 30, 2026-$1.47-$1.28Beat
Feb 3, 2026$2.01$2.04Beat
Oct 30, 2025$2.36$2.58Beat
Jul 29, 2025$2.03$2.13Beat
Apr 24, 2025$2.13$2.22Beat

Analyst view

Consensus price target
$157.94 ▲ +8.7%
Range $105.00 – $180.00
Rating: Buy
Buy 68% · Hold 29% · Sell 3%

Get free alerts on MRK and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.